FB 04 - Universitätsmedizin
Johannes Gutenberg-Universität Mainz
- 06131/17-9704 oder 9799 (Sekretariat)
- 06131/17-9669
Rajab, TK; Wallwiener, CW; Brochhausen, C et al.
Adhesion prophylaxis using a copolymer with rationally designed material propertiesSURGERY. Bd. 145. H. 2. 2009 S. 196-201
Garcia, MM; Shindel, AW; Fandel, TM et al.
ADIPOSE-DERIVED STEM CELLS FOR THE TREATMENT OF DIABETIC ERECTILE DYSFUNCTION IN THE ZDF TYPE-II DIABETIC FATTY RATJOURNAL OF UROLOGY. Bd. 181. H. 4. 2009 S. 44-44
Burger, M; Thiounn, N; Denzinger, N et al.
ADJUVANT AUTOLOGOUS INTRAVESICAL MACROPHAGE CELL THERAPY VS. BCG FOR NON-MUSCLE INVASIVE BLADDER CANCER: A PHASE II, MULTICENTER, RANDOMIZED TRIALEUROPEAN UROLOGY SUPPLEMENTS. Bd. 8. H. 4. 2009 S. 285-285
Tessema, TS; Dauber, E; Petry, F
Adoptive transfer of protective immunity from Cryptosporidium parvum-infected interferon-gamma and interleukin-12-deficient mice to naive recipientsVaccine. Bd. 27. 2009 S. 6575-6581
Goetz, M; Kiesslich, R
Advanced imaging of the gastrointestinal tract: research vs. clinical tools?Curr Opin Gastroenterol. Bd. 25. H. 5. 2009 S. 412-21
West, M; Nicholls, K; Mehta, A et al.
Agalsidase Alfa and Kidney Dysfunction in Fabry DiseaseJ Am Soc Nephrol. Bd. 20. 2009 S. 1132-1139
Beck, M
Agalsidase alfa for the treatment of Fabry desease: new data on clinical efficacy and safetyExpert Opin Biol Ther. Bd. 9. H. 2. 2009 S. 255-261
Feriozzi, S; Schwarting, A; Sunder-Plassmann, G et al.
Agalsidase alfa slows the decline in renal function in patients with Fabry diseaseAm J Nephrol. Bd. 29. H. 5. 2009 S. 353-61
Timaru-Kast, R; Engelhard, K; Werner, C et al.
Age Dependent Differences of Neuronal Damage after Brain Trauma in MiceAnesthesiology. Bd. 111. 2009 S. CD A 1474
Gramley, F; Lorenzen, J; Knackstedt, C et al.
Age-related atrial fibrosis.AGE. Bd. 31. H. 1. 2009 S. 27-38